This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Boyd, M. R. Articles by Reznik-Schüller, H. M. Search for Related Content PubMed PubMed Citation Articles by Boyd, M. R. Articles by Reznik-Schüller, H. M. Social Bookmarking                         What's this?

Metabolic Basis for the Pulmonary Clara Cell as a Target for Pulmonary Carcinogenesis

Laboratory of Experimental Therapeutics and Metabolism, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, Bethesda. Maryland 20205

Hildegard M. Reznik-Schüller

Laboratory of Experimental Therapeutics and Metabolism, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, Bethesda. Maryland 20205

The furan compound, 4-ipomeanol, is activated in lung tissue by cytochrome P-450 dependent oxidation to a highly reactive, electrophilic product that binds covalently to tissue marcomolecules. Although the reactive metabolite(s) of 4-ipomeanol have not yet been definitively identified, recent studies with 3-methylfuran have indicated that a highly reactive, unsaturated dialdehyde is formed from microsomal oxidation and ring-opening of the furan nucleus. Metabolic experiments with 4-ipomeanol in intact lungs, lung slices, lung cells, lung microsomes and purified lung cytochromes P-450, supported the conclusion that the Clara cell is an important locus of cytochrome P-450 monooxygenase activity in lung. In vivo, 4-ipomeanol was bound covalently and caused necrosis preferentially in the pulmonary Clara cells of laboratory animals. Similarly, N-nitrosamines require metabolic activation mediated by the cytochrome P-450 monooxygenase system in the host organism. A number of nitrosamines which are lung carcinogens in rats and hamsters have been shown to bind preferentially to bronchial and bronchiolar Clara cells in these species. Early pathological changes occurred specifically in Clara cells and lung tumors that developed under continuous nitrosamine treatment originated from such altered Clara cells. The well-differentiated counterparts of these tumors clearly retained their ability to bind the nitrosamine that had induced their formation. Thus, the studies on these two different classes of compounds together supported the view that metabolism may be a factor critical to the progenitor role of the Clara cell in chemically-induced bronchogenic lung cancer.

Toxicologic Pathology, Vol. 12, No. 1, 56-61 (1984)
DOI: 10.1177/019262338401200109


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				W. T. Gunning, A. Castonguay, P. J. Goldblatt, and G. D. Stoner Strain A/J Mouse Lung Adenoma Growth Patterns Vary When Induced by Different Carcinogens Toxicol Pathol, February 1, 1991; 19(2): 168 - 175. [Abstract] [PDF]